Testosterone and DHEA-S Secreting Adrenal Cortical Adenoma in a Postmenopausal Woman: A Rare Functional Incidentaloma.

IF 0.7 Q3 MEDICINE, GENERAL & INTERNAL
Crystal M Acosta, Ugur Deniz Ayar, Neeta J Erinjeri, Ron T Varghese
{"title":"Testosterone and DHEA-S Secreting Adrenal Cortical Adenoma in a Postmenopausal Woman: A Rare Functional Incidentaloma.","authors":"Crystal M Acosta, Ugur Deniz Ayar, Neeta J Erinjeri, Ron T Varghese","doi":"10.1177/23247096261498515","DOIUrl":null,"url":null,"abstract":"<p><p>Postmenopausal hyperandrogenism is uncommon and should prompt evaluation for an underlying androgen-secreting source. Although ovarian causes are more frequent, adrenal tumors remain an important consideration and may occasionally be malignant. We report a 53-year-old postmenopausal woman who presented with progressive hirsutism, scalp hair loss, and mild clitoromegaly. Laboratory evaluation showed markedly elevated total testosterone and dehydroepiandrosterone sulfate levels with suppressed gonadotropins. Pelvic ultrasonography showed no ovarian mass. CT demonstrated a 3.5 × 2.4 cm left adrenal mass with precontrast attenuation of 31 Hounsfield units and an enhancement washout pattern not typical of an adrenal adenoma. MRI showed a 3.6 × 2.1 cm left adrenal lesion with arterial hyperenhancement, restricted diffusion, and no signal drop on out-of-phase imaging. Biochemical testing excluded pheochromocytoma, primary aldosteronism, and clinically significant cortisol co-secretion. The patient underwent laparoscopic adrenalectomy, and pathology confirmed a 3.6 cm adrenal cortical adenoma with negative margins, positive inhibin, Melan-A, and steroidogenic factor-1 staining, and Ki-67 <3%. Postoperative androgen levels normalized, and adrenal insufficiency was excluded by cosyntropin stimulation testing. This case highlights the importance of integrating clinical presentation, biochemical localization, adrenal imaging, differential diagnosis, and pathology when evaluating severe postmenopausal hyperandrogenism.</p>","PeriodicalId":16198,"journal":{"name":"Journal of investigative medicine high impact case reports","volume":"14 ","pages":"23247096261498515"},"PeriodicalIF":0.7000,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of investigative medicine high impact case reports","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/23247096261498515","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/10/10 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0

Abstract

Postmenopausal hyperandrogenism is uncommon and should prompt evaluation for an underlying androgen-secreting source. Although ovarian causes are more frequent, adrenal tumors remain an important consideration and may occasionally be malignant. We report a 53-year-old postmenopausal woman who presented with progressive hirsutism, scalp hair loss, and mild clitoromegaly. Laboratory evaluation showed markedly elevated total testosterone and dehydroepiandrosterone sulfate levels with suppressed gonadotropins. Pelvic ultrasonography showed no ovarian mass. CT demonstrated a 3.5 × 2.4 cm left adrenal mass with precontrast attenuation of 31 Hounsfield units and an enhancement washout pattern not typical of an adrenal adenoma. MRI showed a 3.6 × 2.1 cm left adrenal lesion with arterial hyperenhancement, restricted diffusion, and no signal drop on out-of-phase imaging. Biochemical testing excluded pheochromocytoma, primary aldosteronism, and clinically significant cortisol co-secretion. The patient underwent laparoscopic adrenalectomy, and pathology confirmed a 3.6 cm adrenal cortical adenoma with negative margins, positive inhibin, Melan-A, and steroidogenic factor-1 staining, and Ki-67 <3%. Postoperative androgen levels normalized, and adrenal insufficiency was excluded by cosyntropin stimulation testing. This case highlights the importance of integrating clinical presentation, biochemical localization, adrenal imaging, differential diagnosis, and pathology when evaluating severe postmenopausal hyperandrogenism.

绝经后妇女分泌睾酮和脱氢表雄酮s肾上腺皮质腺瘤:罕见的功能性偶发瘤。
绝经后高雄激素是不常见的,应提示评估潜在的雄激素分泌源。虽然卵巢原因更常见,肾上腺肿瘤仍然是一个重要的考虑,可能偶尔是恶性的。我们报告了一位53岁的绝经后妇女,她表现为进行性多毛症、头皮脱发和轻度阴蒂肥大。实验室评估显示总睾酮和硫酸脱氢表雄酮水平明显升高,促性腺激素抑制。盆腔超声检查未见卵巢肿块。CT示左侧肾上腺3.5 × 2.4 cm肿块,对比前衰减31 Hounsfield单位,增强洗脱模式非典型肾上腺腺瘤。MRI示左肾上腺病变3.6 × 2.1 cm,动脉高强化,弥散受限,同期成像无信号下降。生化检测排除嗜铬细胞瘤、原发性醛固酮增多症和临床显著的皮质醇共分泌。患者行腹腔镜肾上腺切除术,病理证实为3.6 cm肾上腺皮质腺瘤,边缘阴性,抑制素、黑色素a和类固醇生成因子-1染色阳性,Ki-67
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
1.90
自引率
0.00%
发文量
165
审稿时长
12 weeks
期刊介绍: The AFMR is committed to enhancing the training and career development of our members and to furthering its mission to facilitate the conduct of research to improve medical care. Case reports represent an important avenue for trainees (interns, residents, and fellows) and early-stage faculty to demonstrate productive, scholarly activity.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书